MELANOMA BRIDGE
December 1st - 3rd, 2022
FACULTY
Sanjiv S. Agarwala
Professor of Hematology & Oncology, Temple University School of Medicine, Philadelphia, PA, US
Paolo A. Ascierto
Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Michael B. Atkins
Deputy Director & Professor, Acting Chief, Division of Hematology/Oncology, Georgetown University Medical School, Washington, DC, US
Allison Betof-Warner
Assistant Attending Physician, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US
Christian Blank
Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute , IRCCS “Fondazione G. Pascale”, Naples, Italy
Richard D. Carvajal
Director of Experimental Therapeutics, Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US
Claudia Piazza Cidonio
Co-Founder, Melanoma Italia Onlus, Rome, Italy
Sandra Demaria
Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology, Weill Cornell Medical College, New York, NY, US
Reinhard Dummer
Vice Director, Department of Dermatology; Director, Clinical Trials Comprehensive Cancer Center Zurich (CCCZ), University Hospital Zurich, Zurich, Switzerland
Alexander M.M. Eggermont
Chief Scientific Officer, Board of Directors, Princess Máxima Center; Professor of Clinical&Translational Immunotherapy, Utrecht University, Utrecht, The Netherlands
Marc S. Ernstoff
Branch Chief, ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy & Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US
Soldano Ferrone
Professor in Residence, Department of Surgery, Harvard Medical School; Immunologist, Department of Surgery, Massachusetts General Hospital, Boston, MA, US
Bernard A. Fox
Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US
Thomas F. Gajewski
Professor of Medicine, Professor of Ben May Department of Cancer Research, Professor of Comprehensive Cancer Research Center, The University of Chicago Medical Center, Chicago, IL, US
Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Director, Integrative Cancer Immunology Team, Cordeliers Research Center, Paris, France
Claus Garbe
Professor of Dermatology, President of the European Association of DermatoOncology (EADO), Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
Brian R. Gastman
Professor, Department of Surgery, School of Medicine, Member of Immune Oncology Program, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, US
Jeffrey E. Gershenwald
Professor of Cancer Biology, Departments of Surgical Oncology and Cancer Biology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Houston, TX, US
Jean-Jacques Grob
Service de Dermatologie et Cancérologie Cutanée Hôpital de la Timone, Aix-Marseille Université Marseille, France
Samantha Guild
President AIM at Melanoma, Richmond, CA, US
Omid Hamid
Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US
Axel Hauschild
Professor of Dermatology, Department of Dermatology, University of Kiel, Kiel, Germany
Pawel Kalinski
SVP, Team Science, Chair, Department of Immunology, Professor of Oncology & Chief, Translational Immuno-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US
Michelle Krogsgaard
Associate Professor of Pathology, Co-leader of Tumor Immunology Program, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US
Rom S. Leidner
Medical Director Head & Neck Cancer Program, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland, OR, US
Roger S. Lo
Professor of Medicine/Dermatology, Associate Chief of Dermatology, Director of the Dermatology STAR Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, US
Jason J. Luke
Director, Immunotherapy and Drug Development Center, Associate Professor of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, US
Francesco Marincola
Senior Vice President, Global Head of Cell Therapy Research, Kite Pharma, Santa Monica, CA, US
Giuseppe Masucci
Associate Professor, Department of Oncology-Pathology and KcRN, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden
Janice M. Mehnert
Professor of Medicine, Associate Director for Clinical Research, Laura and Isaac Perlmutter Cancer Center, Director, Melanoma and Cutaneous Medical Oncology, NYU Grossman School of Medicine, New York, NY,US
Alexander Menzies
Medical Oncologist, Associate Professor of Melanoma Medical Oncology, The University of Sydney; Faculty Member, Melanoma Institute Australia; Chair, Department of Cancer Medicine, Mater Hospital; Chair, Melanoma and Skin Cancer Group, Clinical Oncology Society of Australia, Sydney, Australia
Olivier Michielin
Full Professor, Chair of Precision Oncology Center, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland
Nicola Normanno
Cell Biology and Biotherapy Unit, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Iman Osman
Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US
Giuseppe Palmieri
Full Professor of Medical Oncology, University of Sassari; Immuno-Oncology & Targeted Cancer Biotherapies, Sassari University Hospital; Associate Researcher, Head of Unit of Cancer Genetics, National Research Council (CNR); Head, Institute of Genetic & Biomedical Research (IRGB), Sassari, Italy
Michael A. Postow
Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US
Poulikos I. Poulikakos
Associate Professor, Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, US
Igor Puzanov
Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US
Sergio Quezada
Professor of Cancer Immunology and Immunotherapy, Immune Regulation & Tumour Immunotherapy Lab, CRUK Senior Cancer Research Fellow, UCL Cancer Institute, University College London, London, UK
Jeffrey A. Sosman
Professor of Medicine, Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, US
Hussein A. Tawbi
Deputy Chair and Director of Personalized Cancer Therapy, Department of Melanoma Medical Oncology, Division of Cancer Medicine, Co-Director, MD Anderson Brain Metastasis Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, US
Alessandro Testori
Chairman surgical subgroup, EORTC Melanoma Group, Brussels, Belgium
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US
Jeffrey S. Weber
Deputy Director, Laura and Isaac Perlmutter Cancer Center, Professor of Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, US
Laurence Zitvogel
Group Leader of Tumour immunology and immunotherapy of cancer, Gustave Roussy Institute, National Institute of Health and Medical Research (INSERM), Villejuif, France